about
Zika VirusIs transfusion-transmitted dengue fever a potential public health threat?Amustaline (S-303) treatment inactivates high levels of Zika virus in red blood cell componentsPrevention of transfusion-transmitted Zika virus in French Polynesia, nucleic acid testing versus pathogen inactivationBitten by a bug or a bag? Transfusion-transmitted dengue: a rare complication in the bleeding surgical patient.Delivery of antiviral small interfering RNA with gold nanoparticles inhibits dengue virus infection in vitro.Serodetection of Dengue virus and its antibodies among blood donors in the western region of Saudi Arabia: a preliminary study.High Seroprevalence of Dengue Virus Infection in Blood Donors From Delhi: A Single Centre Study.A neutralization assay for Zika and Dengue viruses using a real-time PCR-based endpoint assessment.Safety of the blood supply.Probable and possible transfusion-transmitted dengue associated with NS1 antigen-negative but RNA confirmed-positive red blood cells.Zika virus and blood transfusion: the experience of French Polynesia.Seroprevalence of Asymptomatic Dengue Virus Infection and Its Antibodies Among Healthy/Eligible Saudi Blood Donors: Findings From Holy Makkah City.Development of a novel dengue virus serotype-specific multiplex real-time reverse transcription-polymerase chain reaction assay for blood screening.Assessing the interest to participate in a dengue vaccine efficacy trial among residents of Puerto Rico.Dengue virus inactivation by minipool TnBP/Triton X-45 treatment of plasma and cryoprecipitate.Estimated prevalence of dengue viremia in Puerto Rican blood donations, 1995 through 2010.Pathogen inactivation of Dengue virus in red blood cells using amustaline and glutathione.
P2860
Q24261255-99163409-6A55-4C63-880A-2A6149FCE6BAQ28085648-42637237-6230-4DE4-BEC3-6588465ED7EDQ28729789-A0C46C1B-6427-4571-80F3-706BCA344768Q28733459-82FC9F94-7302-4F85-8C87-C87A0F4F3D6FQ33420777-739FCD13-A0D1-4805-8C4D-9F21385CB321Q33918636-C7F9B4D1-028D-40BF-9408-902AC2A546A0Q35049183-B3FE2B42-D44C-4F12-B550-6C75E88B3101Q37435384-FF9641AA-A83D-4E0D-9B05-7BD2A275E6A7Q38156849-219EEB8B-381C-4B08-BDE1-8F83FC6AB747Q38287590-80BC0DE2-5BAD-4047-B82F-18A645DBEFD0Q38607800-B30F1E7F-1A6D-43C2-BBF0-5AFBB64B66A6Q38968466-4E5E613D-1C40-4F68-8DC3-34D65B24AE6BQ40058562-4DA149B4-8107-4054-8343-430FFF35B998Q40083125-30B7CC86-E4C4-4EEC-A1D1-70CF219509C5Q40279553-0749B331-B736-4E04-8EF0-F3AD46725A0FQ40281625-48C665EC-A7AE-469B-BC2B-FB0E6D570A90Q40297371-D1BEC4B6-D028-4730-926E-086F74E5880EQ41935541-E20CEF19-4129-492D-A9BD-003050736CD1
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Dengue: a potential transfusion-transmitted disease.
@en
Dengue: a potential transfusion-transmitted disease.
@nl
type
label
Dengue: a potential transfusion-transmitted disease.
@en
Dengue: a potential transfusion-transmitted disease.
@nl
prefLabel
Dengue: a potential transfusion-transmitted disease.
@en
Dengue: a potential transfusion-transmitted disease.
@nl
P2860
P1433
P1476
Dengue: a potential transfusion-transmitted disease.
@en
P2093
Harold S Margolis
Kay M Tomashek
P2860
P304
P356
10.1111/J.1537-2995.2011.03269.X
P577
2011-08-01T00:00:00Z